Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells

https://doi.org/10.1016/0014-4827(92)90360-KGet rights and content

Abstract

Protein kinase C activating phorbol esters downregulated membrane CD4 by endocytosis in U-937 and human T-cells. Half-time for internalization (~15 min at 50 ng/ml PMA) was determined by FACS. CD4-bound 125I-labeled anti-CD4 mAb was rapidly degraded in PMA-activated cells, whereas degradation was low in resting cells. Endocytosis and/or degradation of anti-CD4 mAb was suppressed by H7, and by inhibitors of membrane traffic (Monensin) and lysosome function (methylamine, chloroquine). Immunocytochemistry localized CD4 to the surface of unstimulated T-cells. Upon PMA stimulation occasional labeling was seen in endosomes but whole cell CD4 decreased dramatically. However, methylamine-treated PMA blasts showed accumulation of CD4 in lysosomes and accordingly, pulse-chase experiments in biolabeled cell cultures suggested a manifest reduction of CD4 half-life in response to PMA. Despite their low surface CD4 density, PMA blasts exhibited uptake and accelerated degradation of anti-CD4 mAb. Also, inhibitors of protein synthesis enhanced the PMA-induced downregulation, and membrane CD4 reappeared on fully activated as well as unstimulated cells treated with trypsin. Ongoing CD4 synthesis in activated cells was further evidenced by metabolic labeling and Northern blot analysis demonstrating unaltered or slightly increased CD4 protein and mRNA levels resulting from PMA. Our findings demonstrate that phorbol esters downregulate the cellular CD4 pool by endocytosis and subsequent lysosomal degradation of membrane CD4. Transport of CD4 to the cell surface and CD4 synthesis is unaffected by activation.

References (49)

  • T.J. Braciale et al.

    Immunol. Today

    (1991)
  • S.M.L. Neudorf et al.

    Cell. Immunol

    (1990)
  • C.A. Janeway

    Immunol. Today

    (1989)
  • R.B. Acres et al.

    J. Biol. Chem

    (1986)
  • Y. Minami et al.

    J. Biol. Chem

    (1987)
  • P. Chomczynski et al.

    Anal. Biochem

    (1987)
  • N. Gregersen et al.

    Clin. Chim. Acta

    (1987)
  • P.J. Maddon et al.

    Cell

    (1985)
  • G. Griffiths et al.

    J. Ultrastruct. Res

    (1984)
  • B.K. Møller et al.

    FEBS Lett

    (1990)
  • P.W. Ledger et al.

    Trends Biochem. Sci

    (1984)
  • A. Veillette et al.

    Cell

    (1988)
  • D.R. Alexander et al.

    Immunol. Today

    (1989)
  • P.J. Maddon et al.

    Cell

    (1988)
  • J. Shin et al.

    J. Biol. Chem

    (1991)
  • P.R. Clapham et al.

    Virology

    (1987)
  • G.S. Firestein et al.

    Cell. Immunol

    (1988)
  • C. Doyle et al.

    Nature

    (1987)
  • D. Gay et al.
  • A. Moretta et al.

    Eur. J. Immunol

    (1988)
  • A. Veillette et al.

    Nature

    (1989)
  • K. Saizawa et al.

    Nature

    (1987)
  • C.M. Weyand et al.

    J. Immunol

    (1987)
  • J.D. Lifson et al.

    Immunol. Rev

    (1989)
  • Cited by (84)

    • Post-translational modifications inducing proteasomal degradation to counter HIV-1 infection

      2020, Virus Research
      Citation Excerpt :

      Likewise, multiple viral proteins are involved in degradation of the identical cellular target molecules, and thus specific contributions from each viral protein to virus replication via proteasomal degradation of the target protein may be nearly immeasurable. For example, both Env and Nef affect SERINC-associated virus entry (Chande et al., 2016; Inuzuka et al., 2005; Rosa et al., 2015; Shi et al., 2018; Usami et al., 2015; Wu et al., 2019), Vpu/Env/Nef regulate down-modulation of CD4 on the HIV-1-infected cell surface (Estrabaud et al., 2007; Garcia and Miller, 1991, 1992; Geleziunas et al., 1991; Margottin et al., 1998; Petersen et al., 1992; Schaefer et al., 2008), and so on. However, the relative influence of each viral protein, such as Vpu/Env/Nef, on CD4 reduction is elusive.

    • Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial

      2019, Kidney International
      Citation Excerpt :

      Peripheral blood mononuclear cells were incubated at 2 × 106 cells/ml per well, with phorbol myristate acetate (50 ng/ml), ionomycin (500 ng/ml), and monensin (2 μmol/ml) for 4 hours at 37 °C in 5% CO2.51 Surface staining with anti-CD3 and anti-CD8 antibodies was followed by fixation, permeabilization, and incubation with anti–interferon-γ, anti–interleukin-13, and anti–interleukin-17 to identify Th1, Th2, and Th17 cells, respectively, on T-helper cells (CD3+, CD8-), using fluorescence –1 to gate the populations.52 Cells were acquired on a BD LSR II flow cytometer and data were analyzed with BD FACS Diva version 6.0 (Becton, Dickinson, San Jose, CA).

    • Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells

      2013, Journal of Ethnopharmacology
      Citation Excerpt :

      The antiviral activity of IFN-γ against HBV replication has been demonstrated in HBV transgenic and hepatocyte cell lines (Guidotti and Chisari, 2001; Robek et al., 2002; Park et al., 2005; Parvez et al., 2006). Petersen CM et al. reported that phorbol esters down-regulated the cellular CD4 pool by endocytosis and subsequent lysosomal degradation of membrane CD4 (Petersen et al., 1992). Therefore, in this study, CD3+CD8− cells were considered as CD4+T cells.

    View all citing articles on Scopus

    This study was supported by grants from the P. Carl Petersen Foundation, the Danish Medical Research Council, the Biomembrane Research Center, University of Aarhus, the consul Johannes Fogh-Nielsen and Ella Fogh-Nielsen Foundation, King Christian X Foundation, and the Danish Blood Donors Research Foundation.

    View full text